Analysis of solid tumor mutation profiles in liquid biopsy
Abstract Liquid biopsy is increasingly gaining traction as an alternative to invasive solid tumor biopsies for prognosis, treatment decisions, and disease monitoring. Matched tumor‐plasma samples were collected from 180 patients across different cancers with >90% of the samples below Stage IIIB....
Main Authors: | Sai A. Balaji, Ashwini Shanmugam, Anuradha Chougule, Srikant Sridharan, Kumar Prabhash, Anuradha Arya, Aditya Chaubey, Arun Hariharan, Pandurang Kolekar, Manimala Sen, Aarthi Ravichandran, Shanmukh Katragadda, Satish Sankaran, Saurabh Bhargava, Prashanth Kulkarni, Suchitra Rao, Chinnababu Sunkavalli, Shripad Banavali, Amit Joshi, Vanita Noronha, Amit Dutt, Urvashi Bahadur, Ramesh Hariharan, Vamsi Veeramachaneni, Vaijayanti Gupta |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-11-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.1791 |
Similar Items
-
Comprehensive Development and Implementation of Good Laboratory Practice for NGS Based Targeted Panel on Solid Tumor FFPE Tissues in Diagnostics
by: Anuradha Chougule, et al.
Published: (2022-05-01) -
NRAS mutation in differentiated thyroid cancer
by: Saswata Saha, et al.
Published: (2022-01-01) -
Authors' reply to Krishnamurthy et al.
by: Goutam Santosh Panda, et al.
Published: (2022-01-01) -
Erdafitinib for tumors with FGFR3 mutation: A promising targeted therapy
by: Jaspreet Kaur, et al.
Published: (2023-01-01) -
What to do when your surgeon cuts off the patients′ oxygen supply?
by: Uma Hariharan, et al.
Published: (2015-01-01)